• Linoleic Acid (C18:2) for Oxidative Stress and Lipid Metabol

  2026-06-18

  Linoleic Acid (C18:2(9Z,12Z)), SKU C3108, is a polyunsaturated fatty acid reagent designed for modeling oxidative stress, membrane fluidity, and nutritional deficiency in cell-based and animal studies. It is not suitable for aqueous protocols or long-term stock solution storage but offers high utility in workflows probing redox mechanisms, erythrocyte injury, and epithelial migration.

• PLAC1 as a Prognostic Biomarker and Molecular Target in ccRC

  2026-06-17

  This article reviews a recent study identifying PLAC1 as a prognostic biomarker and therapeutic target in clear cell renal cell carcinoma (ccRCC). The research integrates transcriptomic analysis, experimental validation, and high-throughput virtual screening to reveal PLAC1’s functional role and the inhibitory effects of two small molecules, highlighting new avenues for targeted ccRCC therapy.

• Linoleic Acid (C18:2): Technical Guidance for Laboratory Use

  2026-06-17

  Linoleic Acid (C18:2(9Z,12Z)), SKU C3108, is a polyunsaturated fatty acid reagent for modeling membrane fluidity, oxidative stress, and nutritional deficiency in cell and animal studies. It is not suitable for protocols requiring aqueous solubility or long-term solution storage. Researchers should follow rigorous solution preparation and assay-specific handling to ensure experimental reliability.

• Acetylcysteine in 3D Co-Culture Models: Precision Redox Modu

  2026-06-16

  Explore the advanced use of Acetylcysteine (N-acetyl-L-cysteine) as a strategic antioxidant in 3D organoid-fibroblast co-culture systems for chemoresistance and oxidative stress pathway modulation. This article provides unique, practical guidance for researchers seeking deeper assay control and translational relevance.

• DIDS (4,4'-Diisothiocyanostilbene-2,2'-disulfonic Acid): Bey

  2026-06-16

  Explore the multifaceted roles of DIDS (4,4'-Diisothiocyanostilbene-2,2'-disulfonic Acid) as more than a chloride channel inhibitor. This article bridges new discoveries in cell fate, ER stress, and metastasis, offering advanced insights for research applications.

• Sodium Phosphate Dibasic: Optimizing Aquatic Toxicity Assays

  2026-06-15

  Sodium phosphate dibasic (Na2HPO4) stands out for its unmatched pH stability in aquatic toxicity and molecular biology experiments. This article details actionable workflows, troubleshooting tactics, and real-world insights so researchers can achieve robust, reproducible results when using this high-purity buffer from APExBIO.

• SGI-1027: Workflow-Validated DNMT Inhibitor for Epigenetics

  2026-06-15

  Explore how SGI-1027 (SKU B1622) addresses real-world cell assay challenges in cancer epigenetics research. This article distills scenario-driven Q&A and protocol guidance, equipping biomedical scientists with data-backed strategies for reliable DNA methylation inhibition and tumor suppressor gene reactivation. All recommendations are grounded in peer-reviewed literature and validated product specifications.

• Dasatinib (BMS-354825): Beyond Kinase Inhibition in Cancer M

  2026-06-14

  Explore how Dasatinib (BMS-354825) empowers advanced cancer biology research by dissecting kinase-driven processes and illuminating new translational assay strategies. This article uniquely integrates mechanistic insights and practical protocols, setting it apart in the field.

• TaqI Restriction Endonuclease: Fast, Specific DNA Digestion

  2026-06-13

  TaqI Restriction Endonuclease (SKU K3053) provides rapid, sequence-specific DNA cleavage for researchers requiring efficient digestion of plasmid, PCR, or genomic DNA. It streamlines workflows where fast, reliable sticky-end generation is essential. This enzyme is not suitable for diagnostic or medical purposes; it is intended strictly for research use.

• hiPSC-Derived Intestinal Organoids for Pharmacokinetic Analy

  2026-06-12

  This study presents a streamlined protocol for generating human induced pluripotent stem cell (hiPSC)-derived intestinal organoids, enabling physiologically relevant pharmacokinetic studies. The approach addresses limitations of traditional models and advances the evaluation of drug absorption and metabolism in vitro.

• Carbapenemase Gene Dynamics in CREC: Plasmid Transfer and Re

  2026-06-12

  This study characterizes the prevalence, localization, and transmission of carbapenemase-encoding genes (CEGs) in carbapenem-resistant Enterobacter cloacae (CREC) from eight teaching hospitals in Guangdong, China during the COVID-19 pandemic. The findings reveal high rates of plasmid-mediated multidrug resistance and underscore the critical role of mobile genetic elements in gene dissemination, informing future surveillance and laboratory modeling strategies.

• Allosteric Biosensors Enable In Situ Tracking of Endogenous

  2026-06-11

  This study introduces an allosteric, genetically encoded biosensor (circStep) for real-time visualization of endogenous protein localization and abundance in living cells. The platform overcomes key limitations of traditional tagging and overexpression strategies, offering a robust, minimally invasive tool for studying native protein dynamics and supporting high-throughput drug screening.

• SGI-1027: DNA Methyltransferase Inhibitor for Cancer Epigene

  2026-06-11

  SGI-1027 stands out as a potent DNA methyltransferase inhibitor, offering a non-nucleoside solution for robust gene reactivation and epigenetic modulation in cancer research. This article translates bench-validated workflows into actionable protocols and troubleshooting tactics, empowering researchers to maximize reproducibility and biological insight with APExBIO's trusted compound.

• Tamoxifen in Breast Cancer: Mechanistic Precision and Assay

  2026-06-10

  Explore how Tamoxifen, a selective estrogen receptor modulator, advances breast cancer research through unique mechanistic insights and assay strategies. This article delivers an in-depth analysis that extends beyond standard applications, offering new perspectives on precision experimental design.

• CB-839 (Telaglenastat): Epitranscriptomic Vulnerabilities in

  2026-06-10

  Explore the advanced role of CB-839 (Telaglenastat) in targeting glutamine metabolism and epitranscriptomic vulnerabilities in cancer. This article uniquely integrates recent mechanistic insights into practical assay design, moving beyond workflow guides.

474 records 9/32 page Previous Next First page 上5页 678910 下5页 Last page